1PRAIDOU A, ANDROUDI S, BRAZITIKOS P, et al. Angiogenic growth factors and their inhibitors in diabetic retinopathy[ J]. Curr Diabetes Rev, 2010, 6(5) : 304 -312.
2TATSUYA K, DAVID V, KIYOSHI S, et al. Knockout of insulin and IGF - 1 receptors on vascular endothelial cells protects againstretinal neovascularization [ J ]. J Clin Invest, 2003, 111 ( 12 ) : 1835 - 1842.
3WU Y, ZHANG Q, ANN D K, et al. Increased vascular endothe- lial growth factor may account for elevated level of plasminogen ac- tivator inhibitor - 1 via activating ERK 1/2 in keloid fibroblasts [J]. Am J Physiol Cell Physiol, 2004, 286(4) : 905 -912.
4BRAZIONIS L, ROWLEY K, JENKINS A, et al. Plasminogen activator inhibitor - 1 activity in type 2 diabetes a different relation- ship with coronary heart disease and diabetic retinopathy [ J ]. Ar- terioscler Thromb Vasc Biol, 2008, 28 : 786 -791.
5SZAFLIK J P, WYSOEKI T, KOWALSKI M, et al. An associa- tion between vascular endothelial growth factor gene promoter poly- morphisms and diabetic retinopathy [ J ]. Graefe' s Arch Clin Exp Ophthalmol, 2008, 246 ( 1 ) : 39 - 43.
6NOMA H, FUNATSU H, YAMASHITA H, et al. Regulation of angiogenesis in diabetic retinopathy: possible balance between vas- cular endothelial growth factor and endostatin [ J ]. Arch Ophthal Mol, 2002, 120(8) : 1075 -1080.
8MOORE T C, MOORE J E, KAJI Y, et al. The role of advanced glycation and products in retinal microvascular leukostasis[ J]. In- vest Ophthalmol Vis Sci, 2003, 44(10) : 4457 -4464.
9MAKIKO M, ISAMU Y, MASAKATSU F, et al. MTHFR gene polymorphism as a risk factor for diabetic reinopathy in type 2 dia- betic patients without serum creatinine elevation [ J ]. Diabetes Care, 2003, 26(2): 547-548.
10CYGANEK K, MIRKIEWICZ SIERADZKA B, MALECKI M T, et al. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients[J]. Acta Diabetol, 2006, 43 (4) : 114 - 119.
7Verma R, Khanna P, Mehta B. National programme on prevention and control of diabetes in India: need to focus. Australas Med J, 2012,5(6) :310-315.
8Ding J, Zou Y, Liu N, et al. Strategies of digital fundus photography for screening diabetic retinopathy in a diabetic population in urban China. Ophthalmic Epidemiol, 2012,19 (6) : 414-419.
9Grigsby J, Betts B, Vidro-Kotchan E, et al. A possible role of acrolein in diabetic retinopathy: involvement of a VEGF, rrGF signaling pathway of the retinal pigment epithelium in hyperglycemia. Curt Eye Res, 2012,37( 11 ) : 1045-1053.
10Takada M, Ban Y, Yamamoto G, et al. Periostin, discovered by nano-flow liquid chromatography and mass spectrometry, is a novel marker of diabetic retinopathy. Biochem Biophys Res Commun, 2010,399(2) :221-226.
